Login Register
About Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers
· Chemical Engineering Online
AI summary

Capra Biosciences announced additional investment under its ASPR (HHS) project to advance modular, continuous bioreactor technology for flexible, cost-competitive domestic manufacturing of pharmaceutical APIs, signaling continued progress and increased total backing for its Manassas, VA operations.

How do you think modular continuous bioreactors could change the economics and resilience of U.S.-based API production?

Capra Biosciences receives additional funding for domestic pharmaceutical API biomanufacturing

This article was originally posted on Chemical Engineering.
View article ->

Capra Biosciences, Inc. (Manassas, Virginia), a biomanufacturing company leveraging modular, continuous bioreactor technology to enable flexible, cost-competitive domestic production of pharmaceutical ingredients, today announced continued progress under its project agreement with the Administration for Strategic Preparedness and Response (ASPR; Washington, D.C.), part of the U.S. Department of Health and Human Services (HHS; Washington, D.C.). The additional investment brings Capra’s total […]

The post Capra Biosciences receives additional funding for domestic pharmaceutical API biomanufacturing appeared first on Chemical Engineering.

Login to comment

Login

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description